July 21-22, 2003 in Madrid, Spain
|
• Brain-machine interfaces
• Biometrics
• Mimicking life
• Advanced robotics
• Brain malleability
• Autonomous Bio-MEMS
• Reactive modeling
• Mirroring intelligence
The IT world has been able
to cope with “technological
advancement” because its progress has been built
upon sciences and architectures that were well understood.
But the next wave of strategic computing – grounded
in biology – breaks this pattern. The introduction
of organic components creates possibilities that can't
be imagined within an information infrastructure based
on electronics alone.
The notion of “hybrid” bio-electronic
devices and applications will become commonplace,
leveraging the high-speed and low cost of silicon
technologies
with the unique capabilities of bio-chemical and
biophysical components. Biomechanical sensors in
particular will
have a huge impact.
Advances may lead us to become
the first generation of humans to radically engineer
new life forms. Research
into organic life forms, including plants, animals
and bacteria, will have implications for industries
as diverse as energy, manufacturing, agriculture,
waste disposal, chemicals and food. Our notions
of security
might change as well as developments create new
biometric and even cryptographic opportunities. We're
starting
to harness our understanding of how cells work
to bring us closer to the creation of "thinking" machines.
The same understanding is enabling us to control
the natural disadvantages of human engineering.
As science
fiction is becoming fact, there will soon be a
little cyborg in all of us. Digital taps will open
a flood
of new personal data. Who will own, manage, and
maintain it?
None of this would be happening
without pervasive
computing, advances in miniaturization, and the
integration of
biology, physiology, chemistry, and computing.
The business opportunities around these new life
systems
are vast, but the consequences for us as a species
are far greater. back to top
Dr. Noubar Afeyan, Senior
Managing Director and CEO, Flagship Ventures
Mr. Richard Bennett, CEO,
Tarian Technology
Dr. Adam Heller, Professor,
Chemical Engineering, University of Texas, Austin
Dr. David Hillis, Professor,
Integrative Biology, University of Texas, Austin
Dr. Chih-Ming Ho, Director,
Institute for Cell Mimetic Space Exploration (CMISE),
UCLA
Dr. Eric Mayes, CEO, Nanomagnetics
Ltd.
Ms. Dawn Meyerriecks, Chief
Technology Officer, Defense Information Systems Agency
(DISA)
Mr. David Neilson, Senior
Director, Global Information Solutions, Worldwide Drug
Discovery, Johnson & Johnson
Pharmaceutical Research & Development
Dr. Jay Neitz, Professor,
Department of Cell Biology, Neurobiology and Anatomy,
Medical College of Wisconsin
Dr. Toribio Fernández
Otero, Professor
of Physical Chemistry, Polytechnic University of Cartagena
Mr. Stephen Petranek, Editor-in-Chief,
Discover
Dr. Steven M. Potter, Assistant
Professor, Laboratory for NeuroEngineering, Georgia Institute
of Technology
Dr. Ehud Shapiro, Professor,
Computer Science and Applied Math, Weizmann Institute
of Science
back to top
|